We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$11B
AUM Growth
-$171M
Cap. Flow
-$101M
Cap. Flow %
-0.92%
Top 10 Hldgs %
51.58%
Holding
48
New
3
Increased
17
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$175M
2
DIS icon
Walt Disney
DIS
+$154M
3
HUM icon
Humana
HUM
+$113M
4
HCA icon
HCA Healthcare
HCA
+$102M
5
DVA icon
DaVita
DVA
+$96.8M

Sector Composition

Rank Sector Weight
1 Healthcare 55.59%
2 Materials 11.67%
3 Technology 10.83%
4 Communication Services 10.2%
5 Industrials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
1
Cigna
CI
$72.4B
$781M 7.08%
4,955,640
+578,749
+13% +$90.7M
HCA icon
2
HCA Healthcare
HCA
$86.8B
$682M 6.18%
5,048,066
+804,562
+19% +$102M
IQV icon
3
IQVIA
IQV
$37.6B
$623M 5.65%
3,872,023
-38,484
-1% -$5.4M
FMC icon
4
FMC
FMC
$1.32B
$620M 5.62%
7,478,180
-1,689,082
-18% -$133M
MCK icon
5
McKesson
MCK
$97.2B
$606M 5.49%
4,505,619
-413,288
-8% -$51.5M
DXC icon
6
DXC Technology
DXC
$1.76B
$603M 5.47%
10,938,889
-55,479
-0.5% -$3.21M
HOLX
7
DELISTED
Hologic
HOLX
$469M 4.25%
9,775,247
-983,303
-9% -$45.5M
TAK icon
8
Takeda Pharmaceutical
TAK
$52.9B
$468M 4.24%
26,430,828
+318,168
+1% +$5.79M
HUM icon
9
Humana
HUM
$43.5B
$466M 4.23%
1,757,402
+445,363
+34% +$113M
FDC
10
DELISTED
First Data Corporation
FDC
$373M 3.38%
13,770,407
-783,224
-5% -$20.4M
THC icon
11
Tenet Healthcare
THC
$20.4B
$370M 3.35%
17,916,896
+15,968
+0.1% +$368K
LYB icon
12
LyondellBasell Industries
LYB
$19.7B
$356M 3.23%
4,132,148
-159,421
-4% -$13.6M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.62T
$320M 2.9%
5,913,180
-2,206,580
-27% -$128M
DIS icon
14
Walt Disney
DIS
$170B
$263M 2.38%
1,882,898
+1,163,697
+162% +$154M
ELV icon
15
Elevance Health
ELV
$82B
$246M 2.23%
870,817
-147,420
-14% -$40.3M
BHC icon
16
Bausch Health
BHC
$2.41B
$245M 2.22%
9,715,244
+400,000
+4% +$9.5M
NXPI icon
17
NXP Semiconductors
NXPI
$59.9B
$233M 2.11%
2,388,888
-849,782
-26% -$82.3M
UHS icon
18
Universal Health Services
UHS
$10.2B
$233M 2.11%
1,786,710
-271,414
-13% -$34.2M
PARA
19
DELISTED
Paramount Global Class B
PARA
$207M 1.88%
4,147,401
+18,164
+0.4% +$899K
WMB icon
20
Williams Companies
WMB
$87.5B
$206M 1.86%
7,335,812
-152,889
-2% -$4.25M
FLEX icon
21
Flex
FLEX
$46.8B
$185M 1.68%
25,647,956
-1,613,732
-6% -$12.4M
DVA icon
22
DaVita
DVA
$14.6B
$182M 1.65%
3,235,712
+1,869,214
+137% +$96.8M
UNH icon
23
UnitedHealth
UNH
$370B
$177M 1.61%
+726,468
New +$175M
MTOR
24
DELISTED
MERITOR, Inc.
MTOR
$175M 1.58%
7,207,435
-491,766
-6% -$11.1M
TMO icon
25
Thermo Fisher Scientific
TMO
$209B
$162M 1.47%
550,564
-430,025
-44% -$118M

Similar funds

Glenview Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Glenview Capital Management held 48 positions worth $11B, down 1.5% from $11.2B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Glenview Capital Management's Q2 2019 filing shows 3 new, 17 increased, 23 reduced and 2 closed positions. Its largest new stake was UnitedHealth: 726,468 shares worth $177M. The largest sale was Microsoft, an estimated $169M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Materials and Technology.

  • Glenview Capital Management's largest Q2 2019 buy was UnitedHealth: 726,468 shares worth $177M.
  • Glenview Capital Management added most to Walt Disney in Q2 2019, an estimated $154M increase.
  • Glenview Capital Management's biggest Q2 2019 reduction was Microsoft, cutting an estimated $169M.
  • Glenview Capital Management fully exited Hertz Global Holdings, Inc. in Q2 2019, selling an estimated $42M.
  • Glenview Capital Management's ten largest holdings make up 52% of its $11B portfolio in Q2 2019.
  • Glenview Capital Management opened 3 new positions and closed 2 in Q2 2019.
  • Glenview Capital Management's portfolio value fell 1.5% quarter-over-quarter to $11B.

Based on Glenview Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.